Negative Molecular Diagnostics in Non-Syndromic Hearing Loss: What Next?
Ontology highlight
ABSTRACT: Congenital hearing loss has an impact on almost every facet of life. In more than 50% of cases, a genetic cause can be identified. Currently, extensive genetic testing is available, although the etiology of some patients with obvious familial hearing loss remains unknown. We selected a cohort of mutation-negative patients to optimize the diagnostic yield for genetic hearing impairment. In this retrospective study, 21 patients (17 families) with negative molecular diagnostics for non-syndromic hearing loss (gene panel analysis) were included based on a positive family history with a similar type of hearing loss. Additional genetic testing was performed using a whole exome sequencing panel (WESHL panel v2.0) in four families with the strongest likelihood of genetic hearing impairment. In thi
SUBMITTER: Clabout T
PROVIDER: S-EPMC9859074 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA